Amgen Inc's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Long-Term-Assets" stands at 62.26 Billion United States Dollars as of 09/30/2025.
As of the end of Amgen Inc's third quarter, the item "Total Long Term Assets" stands at 62.26 Billion USD. This represents an increase of 1.79 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.90 percent compared to the value the year prior.
The 1 year change in percent is -2.90.
The 3 year change in percent is 57.06.
The 5 year change in percent is 48.31.
The 10 year change in percent is 88.51.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Long Term Assets | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Long Term Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Long Term Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Long Term Assets | 280,205,508,085.11 |